The added value of technology and innovation in healthcare can only reach its full potential if the right strategic choices are made.

Life Science companies and healthcare organizations

working with innovative solutions can count on my support.

Click on the buttons below to find out more


Life Sciences Companies

A clear strategy is essential to make the right choices and define the best route to success for impactful medical innovations. It ensures effective direction of activities in the company, accelerates decision-making and is convincing for investors. And leads to the right Go-To-Market strategy, fast track market entry, high quality, proper implementation in healthcare and a good fit into patients’ lives are essential elements. Only with the right challenging questions and sharp analysis the best strategy and tactics can be chosen for such complex matters.

Looking for a sparring partner for making a succes of your e-health solution, medical device or gene therapy? Feel free to contact me.


Healthcare Organisations

Effective implementation of innovative healthcare technology starts with a strategic direction based on a future perspective for the organization. Only with a clear direction and well-thought-out implementation, technology solutions become a true part of daily practice and support the organisations objectives. Resulting in improving outcomes of care for patients or more convenient processes for healthcare professionals. This requires knowledge and experience, strong social skills and inspiring leadership.

Looking for support with the digital strategy or implementation of innovation? Give me a call !


Naomi Tielen, PharmD

Consultant / Owner

+31 6 1337 9775

naomi@canvashealthcare.consulting

https://www.linkedin.com/in/naomi-tielen/


My Vision

The right use of technology and innovation can substantially improve the health and well-being of patients in their daily live. Knowledge exchange and alignment the needs and opportunities of innovative companies, healthcare professionals and patients is crucial.

Summary of knowledge and experience

I have experience in leading value-driven programs for medical companies and healthcare organisations, as well as implementation of e-health solutions in medical practice. Therefore, I know how to manage these multidimensional challenges. In this I bring my strategic insight, genuine interest in people, analytical skills, process thinking and my solution-oriented approach.

Leading innovation programs

  • Program lead Value Based Programs
  • Program lead digitalization and e-health

Strategy development and execution

  • Business strategy validation (gene therapy)
  • Value Based HealthCare strategy for several indications (VBHC)
  • Product- and brand strategy (pharma)
  • Strategic patient support programs

Stakeholdermanagement

  • Close collaboration with healthcare professionals and patients
  • Negotiation and engagement lawyers, buyers, c-suite
  • Leading multidisciplinary teams (R&D-teams, product owners, RA, QA and KOLs)

Change management

  • Guiding process changes for innovation in medical teams
  • Resistance management
  • Collaboration stimulation

Innovation for patient and company

  • Development and implementation e-health solutions
  • Innovative and life saving medtech product development

Publications

Business case psychosocial interventions in fertility

Kaptein, A. A., et al., 2024, Business case for psychosocial interventions in clinics: potential for decrease in treatment discontinuation and costs, Reproductive Biomedicine Online, Volume 49, ISSUE 3, 104113, September 2024

Funding as a barrier to value based healthcare implementation in the Netherlands

Middelveldt, I., Tielen, N., Van Hoof, G., Van der Linde, M., Waarom zit het systeem vast? Belemmeringen die Waardegedreven Zorg in de weg staan: een diagnose, 2024, Whitepaper Linnean Werkgroep

Value based healthcare is about outcomes and costs

Van den Hout, W., Tielen, N., Van der Kooij, J., Naber, P., Van der Poort, E., Regts, G., Fröhlke, M., Middelveldt, I., Van der Linde, M., 2021, Waardegedreven zorg met uitkomsten én kosten, Whitepaper Linnean Werkgroep

Innovative drug delivery technology

Keurentjes, J. T. F., et al., 2009, Externally Triggered Glass Transition Switch for Localized On-Demand Drug Delivery, Angewandte Chemie, Volume48, Issue52, December 21, 2009, Pages 9867-9870


Customers and partners in the recent years

Zeeuwse Zorg Coalitie
Amgen
Ventinova BV
Ferring BV
Erasmus MC
Radboud UMC
UMCG
Albert Schweitzer ziekenhuis
Jeroen Bosch ziekenhuis
ETZ
Maxima MC
TFP - the fertility partner
Diakonessenhuis Utrecht
Nij LInge
Nij Geertgen